Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

Overview of attention for article published in BMC Cancer, October 2010

Altmetric Badge

Mentioned by

patent: 1 patent

Readers on

mendeley: 40 Mendeley
citeulike: 2 CiteULike

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

STABILIZED EZH2 PEPTIDES

Application WO-2014151369-A2

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.